MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
AMED - Amedisys Inc.
$91.50
0.52(0.57%)9:00:00 PM 12/2/2022
Amedisys Home Health and Hospice Care , based in Baton Rouge, Louisiana, is one of the largest home health providers and second largest hospice care provider in the United States. Amedisys provides in-home skilled nursing, physical therapy, occupational therapy and speech language pathology, medical social work, home aides, and hospice and bereavement services, with 11 million patient care visits in 2011.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • MACD is crossing MACD signal line at 0.9. MACD crossing signal line is bullish signal.
Stock Statistics
MarketCap3B
PE Ratio24.7
PEG Ratio3.1
P/B9.9
P/S (ttm)3.7
Earning Growth (QoQ)57%
Revenue Growth (QoQ)
Short %2%
Held by Institutions %91%
1 Day Vol Adjusted Return0.2
1 Month Vol Adjusted Return0.8
3 Month Vol Adjusted Return-7.1
6 Month Vol Adjusted Return-6.5
20 Days SMA Price ZScore1.2
50 Days SMA Price ZScore-0.4
12 -26 Days PPO-1.3
1 Month Average Short Volume Ratio42.8
1 Day Volume Change ZScore-1.2
1 Month Daily Vol2.4
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    11/22/2022AMED
    Amedisys Names Scott Ginn Acting Chief Operating Officer

    BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately. “I am delighted to have Scott Ginn serving as a trusted partner in this critical role on our leadership team,” stated Paul Kusserow, Chairman and CEO of Amedisys. “Scott is well respected within Amedisys an

    11/20/2022AMED
    Last week in management changes and dispatches: Visa, Tesla

    Here are the biggest management changes and dispatches from the past week, as first reported on InvestingPro+.

    11/18/2022AMED
    Amedisys Inc. terminates president and CEO, effective immediately

    A publicly traded home health and hospice company is shaking up its C-suite. The company’s board of directors appointed Amedisys Chairman and former CEO Paul Kusserow as interim CEO until a permanent replacement is found. Kusserow previously worked as Amedisys’ CEO from 2014 until April, when Gerard was hired.

    11/18/2022AMED
    Are Options Traders Betting on a Big Move in Amedisys (AMED) Stock?

    Investors need to pay close attention to Amedisys (AMED) stock based on the movements in the options market lately.

    11/18/2022AMED
    Amedisys Confirms Full Year Guidance

    Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022, and Paul Kusserow, Chair of the Board of Directors will take over as Chief Executive Officer until a new Chief Executive Officer is identified.

    11/17/2022AMED
    Amedisys Announces CEO Departure

    Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022.

    11/8/2022AMED
    Amedisys Third Quarter 2022 Earnings: Misses Expectations

    Amedisys ( NASDAQ:AMED ) Third Quarter 2022 Results Key Financial Results Revenue: US$558.0m (flat on 3Q 2021). Net...

    11/3/2022AMED
    Is There An Opportunity With Amedisys, Inc.'s (NASDAQ:AMED) 30% Undervaluation?

    Today we will run through one way of estimating the intrinsic value of Amedisys, Inc. ( NASDAQ:AMED ) by projecting its...

    11/1/2022AMED
    Amedisys Statement on CY 2023 Home Health Final Rule

    BATON ROUGE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, issued the following statement following the CY 2023 Home Health Final Rule by the Centers for Medicare and Medicaid Services (CMS). “While not the ideal outcome, today’s release of the CY 2023 Home Health Final Rule is a welcomed improvement over what was proposed by CMS this summer in regard to the overall payment update for

    10/31/2022AMED
    Amedisys (AMED) Q3 Earnings Miss Estimates, Guidance Cut

    Within Amedisys (AMED) Home Health and Hospice, the reinstatement of sequestration reduces growth in Q3.